| Financial Year |
March 31 2023 |
| Monetary Funds |
555,461,944.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,900,000.00 |
| Accounts Receivable |
406,832,560.42 |
| Advances to Suppliers |
62,683,984.88 |
| Other Receivables |
46,161,656.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
750,635,488.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,373,022.39 |
| Total Current Assets |
1,852,348,656.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
27,429,724.99 |
| Long-term Equity Investment |
439,206,060.82 |
| Investment Properties |
-- |
| Fixed Assetes |
291,615,631.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
97,199,615.66 |
| R&D expenses |
-- |
| Goodwill |
1,439,747,923.35 |
| Long-Term Deferred and Prepaid Expenses |
20,787,445.47 |
| Deferred Income Tax Assets |
262,516,078.46 |
| Other Non-Current Assets |
2,693,913.85 |
| Sub-Total of Non-Current Assets |
3,296,110,651.72 |
| Total Assets |
5,148,459,308.24 |
| Short-Term Loans |
798,348,256.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
346,072,315.70 |
| Accounts Received In Advance |
14,394,339.62 |
| Employee Compensation Payable |
56,139,543.77 |
| Taxes Payable |
15,107,113.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,338,351.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
123,993,885.89 |
| Other Current Liabilities |
8,615,697.44 |
| Sub-Total of Current Liabilities |
1,511,527,080.64 |
| Long-term Loans |
128,632,444.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,844,512.31 |
| Deferred Income Tax Liabilities |
1,737,487.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
354,266,866.85 |
| Total Liabilities |
1,865,793,947.49 |
| Paid-In Capital(Or Share Stock) |
1,478,699,697.00 |
| Capital Surplus |
2,467,083,792.03 |
| Surplus Reserve |
232,503,266.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-796,962,930.43 |
| Minority Stockholder's Interest |
26,494,203.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,256,171,157.31 |
| Owner's Equity（Stockholder's Equity） |
3,282,665,360.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,148,459,308.24 |
